{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:29:15Z","timestamp":1780457355402,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017202","name":"HM Hospitals Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004313","name":"General Electric Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jns.2025.123510","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:24:01Z","timestamp":1744878241000},"page":"123510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis"],"prefix":"10.1016","volume":"473","author":[{"given":"Clara","family":"Trompeta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gasca-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rodr\u00edguez-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Clarim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Garc\u00eda-Ca\u00f1amaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Hern\u00e1ndez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"S\u00e1nchez-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Olazar\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Vela-Desojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0020","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0891988712464823","article-title":"Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden","volume":"25","author":"Leroi","year":"2012","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","article-title":"Cortical Lewy body pathology in the diagnosis of dementia","volume":"102","author":"Harding","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0035","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20635","article-title":"Neuropathology of dementia in Parkinson\u2019s disease: a prospective, community-based study","volume":"58","author":"Aarsland","year":"2012","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","article-title":"Parkinson disease with dementia: comparing patients with and without Alzheimer pathology","volume":"23","author":"Sabbagh","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0045","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0050","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.27867","article-title":"Pathological influences on clinical heterogeneity in Lewy body diseases","volume":"35","author":"Coughlin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2025.123510_bb0060","first-page":"1234","article-title":"Neuropathology of dementia in patients with parkinson\u2019s disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0065","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"The Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0080","article-title":"The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study","volume":"3","author":"Biundo","year":"2021","journal-title":"Brain Communicat."},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0085","article-title":"Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types","volume":"145","author":"Harrington","year":"1994","journal-title":"Am. J. Patbol."},{"key":"10.1016\/j.jns.2025.123510_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK biobank","volume":"59","author":"Lumsden","year":"2020","journal-title":"eBioMedicine"},{"issue":"9","key":"10.1016\/j.jns.2025.123510_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2025.123510_bb0100","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2025.123510_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-010-0755-1","article-title":"Neuropathology in Parkinson\u2019s disease with mild cognitive impairment","volume":"120","author":"Jellinger","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pjnns.2018.04.003","article-title":"The impact of apolipoprotein E alleles on cognitive performance in patients with Parkinson\u2019s disease","volume":"52","author":"Pierzchli\u0144ska","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/gps.5260","article-title":"Systematic review of genetic association studies in people with Lewy body dementia","volume":"35","author":"Sanghvi","year":"2020","journal-title":"Int. J. Geriat. Psychiatr."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2025.123510_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.631145","article-title":"APOE and MAPT are associated with dementia in Neuropathologically confirmed Parkinson\u2019s disease","volume":"12","author":"Tunold","year":"2021","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","article-title":"Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology","volume":"131","author":"Toledo","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0140","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/ijms25031795","article-title":"Apolipoprotein E gene in \u03b1-Synucleinopathies: a narrative review","volume":"25","author":"Liampas","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.jns.2025.123510_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9497147","article-title":"Meta-analysis of the relationship between the APOE gene and the onset of Parkinson\u2019s disease dementia","volume":"2018","author":"Pang","year":"2018","journal-title":"Parkinson\u2019s Disease"},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0150","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1212\/WNL.54.6.1272","article-title":"APOE and the risk of PD with or without dementia in a population-based study","volume":"54","author":"Harhangi","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2025.123510_bb0155","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00415-020-09757-9","article-title":"Predictors of cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies","volume":"268","author":"Guo","year":"2021","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2025.123510_bb0160","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.62.8.1265","article-title":"Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam study","volume":"62","author":"De Lau","year":"2005","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2025.123510_bb0170","series-title":"(2008): WAIS-IV. Escala de inteligencia de Wechsler para adultos-IV. Manual de aplicaci\u00f3n y correcci\u00f3n","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.jns.2025.123510_bb0175","first-page":"11","article-title":"Partington\u2019s pathway test","volume":"1","author":"Partington","year":"1949","journal-title":"Psychol Serv Cent J"},{"issue":"9","key":"10.1016\/j.jns.2025.123510_bb0180","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123510_bb0185","series-title":"Escala de Memoria de Wechsler","author":"Wechsler","year":"2013"},{"key":"10.1016\/j.jns.2025.123510_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0028-3932(67)90015-2","article-title":"Word fluency and brain damage","volume":"5","author":"Borkowski","year":"1967","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.jns.2025.123510_bb0195","series-title":"Stroop Color and Word Test: A Manual for Clinical and Experimental Uses","first-page":"24","author":"Golden","year":"1978"},{"key":"10.1016\/j.jns.2025.123510_bb0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1192\/bjp.123.4.467","article-title":"The set test as an aid to the detection of dementia in old people","volume":"123","author":"Isaacs","year":"1973","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jns.2025.123510_bb0205","series-title":"Boston Naming Test","author":"Kaplan","year":"1983"},{"key":"10.1016\/j.jns.2025.123510_bb0210","series-title":"Contributions to Neuropsychological Assessment","author":"Benton","year":"1994"},{"key":"10.1016\/j.jns.2025.123510_bb0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1076\/jcen.20.2.211.1169","article-title":"Validation of the Warrington theory of visual processing and the visual object and space perception battery","volume":"20","author":"Rapport","year":"1998","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"7","key":"10.1016\/j.jns.2025.123510_bb0220","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2967\/jnumed.115.156000","article-title":"Whole-body PET\/MR imaging: quantitative evaluation of a novel model-based MR attenuation correction method including bone","volume":"56","author":"Paulus","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jns.2025.123510_bb0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","article-title":"Measurement of radiotracer concentration in brain Gray matter using positron emission tomography: MRI-based correction for partial volume effects","volume":"12","author":"M\u00fcller-G\u00e4rtner","year":"1992","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2025.123510_bb0235","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuroimage.2016.12.077","article-title":"PETPVE12: an SPM toolbox for partial volume effects correction in brain PET \u2013 application to amyloid imaging with AV45-PET","volume":"147","author":"Gonzalez-Escamilla","year":"2017","journal-title":"NeuroImage"},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0240","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jalz.2017.03.007","article-title":"Cerebral amyloid angiopathy in down syndrome and sporadic and autosomal-dominant Alzheimer\u2019s disease","volume":"13","author":"Carmona-Iragui","year":"2017","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hbm.1058","article-title":"Nonparametric permutation tests for functional neuroimaging: a primer with examples","volume":"15","author":"Nichols","year":"2002","journal-title":"Hum. Brain Mapp."},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.parkreldis.2014.02.001","article-title":"Clinical and pathologic presentation in Parkinson\u2019s disease by apolipoprotein e4 allele status","volume":"20","author":"Monsell","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0255","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","article-title":"APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology","volume":"143","author":"Jin","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"5\u20136","key":"10.1016\/j.jns.2025.123510_bb0260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000464322","article-title":"Extremely low prevalence of amyloid positron emission tomography positivity in Parkinson\u2019s disease without dementia","volume":"77","author":"Mashima","year":"2017","journal-title":"Eur. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177924","article-title":"Regional brain amyloid-\u03b2 accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. Ginsberg SD, editor","volume":"12","author":"Akhtar","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13041-022-00964-1","article-title":"Beta amyloid deposition and cognitive decline in Parkinson\u2019s disease: a study of the PPMI cohort","volume":"15","author":"Mihaescu","year":"2022","journal-title":"Mol. Brain"},{"issue":"12","key":"10.1016\/j.jns.2025.123510_bb0275","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25707","article-title":"Dopaminergic depletion, \u03b2-amyloid burden, and cognition in Lewy body disease","volume":"87","author":"Yoo","year":"2020","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2025.123510_bb0285","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/brain\/aww193","article-title":"Amyloid-\u03b2 deposition and regional grey matter atrophy rates in dementia with Lewy bodies","volume":"139","author":"Sarro","year":"2016","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0290","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0295","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0300","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","article-title":"Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson\u2019s disease","volume":"39","author":"Garcia-Garcia","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0305","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JPD-140398","article-title":"Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson\u2019s disease","volume":"4","author":"Gasca-Salas","year":"2014","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.jns.2025.123510_bb0310","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-\u03b2 pathology in Parkinson disease and dementia with Lewy bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123510_bb0315","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-190323","article-title":"Clinical correlates of cerebral amyloid deposition in Parkinson\u2019s disease dementia: evidence from a PET study. Cagnin a, editor","volume":"70","author":"Palermo","year":"2019","journal-title":"JAD"},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0320","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.jns.2025.123510_bb0325","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1533317514525655","article-title":"Cognitive, neuropsychiatric, and motor features associated with apolipoprotein E \u220a4 allele in a sample of Bulgarian patients with late-onset Parkinson\u2019s disease","volume":"29","author":"Pavlova","year":"2014","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"10.1016\/j.jns.2025.123510_bb0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2023.07.011","article-title":"Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson\u2019s disease","volume":"131","author":"Zenuni","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2025.123510_bb0335","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2021.01.004","article-title":"Impact of the apolipoprotein E \u03b54 allele on early Parkinson\u2019s disease progression","volume":"83","author":"Kim","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.jns.2025.123510_bb0340","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/mds.27002","article-title":"Mild cognitive impairment as a risk factor for Parkinson\u2019s disease dementia","volume":"32","author":"Hoogland","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0350","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.24628","article-title":"APOE2 eases cognitive decline during aging: clinical and preclinical evaluations","volume":"79","author":"Shinohara","year":"2016","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0355","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/jgs.15727","article-title":"Apolipoprotein E genotypes, age, race, and cognitive decline in a population sample","volume":"67","author":"Rajan","year":"2019","journal-title":"J. Am. Geriat. Soc."},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0360","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1037\/neu0000501","article-title":"Effects of APOE on cognitive aging in community-dwelling older adults","volume":"33","author":"Reas","year":"2019","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.jns.2025.123510_bb0365","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and a\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jns.2025.123510_bb0370","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-201205","article-title":"APOE E2\/E2 is associated with slower rate of cognitive decline with age. Rissman R, editor","volume":"83","author":"Sweigart","year":"2021","journal-title":"JAD"},{"issue":"7","key":"10.1016\/j.jns.2025.123510_bb0375","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s00259-021-05192-8","article-title":"Differential associations of APOE-\u03b52 and APOE-\u03b54 alleles with PET-measured amyloid-\u03b2 and tau deposition in older individuals without dementia","volume":"48","author":"Salvad\u00f3","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"17","key":"10.1016\/j.jns.2025.123510_bb0380","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010811","article-title":"Association between APOE \u03b52 and a\u03b2 burden in patients with Alzheimer- and vascular-type cognitive impairment","volume":"95","author":"Lee","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2025.123510_bb0385","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/mds.28932","article-title":"GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study","volume":"37","author":"Szwedo","year":"2022","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0390","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s40001-024-01924-2","article-title":"Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson\u2019s disease","volume":"29","author":"Zhu","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"12","key":"10.1016\/j.jns.2025.123510_bb0395","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/aje\/kwr015","article-title":"Variations in apolipoprotein E frequency with age in a pooled analysis of a large Group of Older People","volume":"173","author":"McKay","year":"2011","journal-title":"Am. J. Epidemiol."},{"issue":"16","key":"10.1016\/j.jns.2025.123510_bb0400","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a Meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2025.123510_bb0405","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","article-title":"APOE- \u03b52 allele associated with higher prevalence of sporadic Parkinson disease","author":"Huang","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2025.123510_bb0410","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/A\u03b242 predict cognitive decline in Parkinson\u2019s disease","volume":"21","author":"Liu","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"11","key":"10.1016\/j.jns.2025.123510_bb0415","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2025.123510_bb0420","doi-asserted-by":"crossref","first-page":"1145939","DOI":"10.3389\/fneur.2023.1145939","article-title":"Tau-PET imaging in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0425","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-191774","article-title":"Tau tangles in Parkinson\u2019s disease: a 2-year follow-up Flortaucipir PET study","volume":"10","author":"Hansen","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.jns.2025.123510_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2025.123510_bb0435","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"s1","key":"10.1016\/j.jns.2025.123510_bb0440","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The Synucleinopathies: Twenty Years On","volume":"7","author":"Goedert","year":"2017","journal-title":"JPD"},{"key":"10.1016\/j.jns.2025.123510_bb0445","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.jns.2025.123510_bb0450","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.56.6.730","article-title":"Risk of dementia in Parkinson\u2019s disease: a community-based, prospective study","volume":"56","author":"Aarsland","year":"2001","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:51:54Z","timestamp":1762210314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":90,"alternative-id":["S0022510X25001273"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123510","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123510"}}